• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EMD

EMYRIA LIMITED - Charts / Financials

3.77% ! 5.5¢
Market Cap $33.45M  !
Technology Health Information Services
Add to My Watchlist

Emyria Limited is an Australia-based early-stage drug development company. The Company is... Emyria Limited is an Australia-based early-stage drug development company. The Company is focused on delivering and developing treatments for mental health and select neurological conditions, guided by real-world data collected with patients across its wholly owned clinical service subsidiaries. Its pipeline comprises MDMA analogue drug development and commercialization of novel serotonin-releasing agents. Its Emyria Healthcare provides evidence-based treatment for patients not finding relief from conventional care, while also helping evaluate emerging new therapies like assisted therapy for post-traumatic stress disorder (PTSD) and assisted therapy for treatment-resistant depression. Its Emyria Data is a robust and ethically sourced real-world data gathered with patients and used to improve its therapy and drug development programs. Its Emyria’s Pipeline includes new psychedelic-assisted therapies and drug treatments for mental health and select neurological diseases.More

refresh Created with Sketch. REFRESH
Last update - 16.10pm 05/12/2025 (20 minute delay) ?
Day
Open 5.3¢   Day High 5.6¢   Day Low 5.3¢
Daily Volume 1075807
Bids   Sellers
Number Price Volume   Number Price Volume
0 5.5¢ 150000   0 5.6¢ 265870

Directors & Senior Management

Dr. Alistair Vickery Executive Medical Director & Director
Dr. David Putrino Member of Medical Advisory Board
Mr. Gregory Hutchinson Executive Chairman
Dr. Henry William Bosch Member of Medical Advisory Board
Dr. Jennifer Morgan Member of Medical Advisory Board
Sir John Edward Tooke Member of Medical Advisory Board & Independent Non-Executive Director
Mr. Joseph Daniel Ohayon Chief Financial Officer
Dr. Karen L. Smith Non-Executive Director & Chairman of Strategic Advisory Board
Mary-Ann Rennie Head of Corporate Operations
Dr. Michael Winlo Chief Scientific Officer & Executive Director
Dr. Mohit Kaushal Non-Executive Director
Prof. Nik Zeps Member of Medical Advisory Board
Dr. Philip Finch Member of Medical Advisory Board
Dr. Richard Magtengaard Member of Medical Advisory Board
Ms. Susan Patricia Park Company Secretary
Ms. Tracie Ernenwein Head of Research & Drug Development

Data source: ADVFN

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
5.5¢ 		Change
0.002(3.77%) 		Mkt cap ! $33.45M
Open High Low Volume
5.3¢ 5.6¢ 5.3¢ 1.075M

Buyers (Bids)

Vol. Price($)
150000 5.5¢
 

Sellers (Offers)

Price($) Vol.
5.6¢ 265870
Last trade - 16.10pm 05/12/2025 (20 minute delay) ?

Top Stories

Live: HotCopper Wire Podcast 034 – Not so jolly December and yet another ASX bungle

In this HotCopper Wire Week 49 episode, we talk about the ASX Ltd bungle that left as many as 80 stocks high and dry, and more.
Pantoro, WEB, Energy One: All the biggest ASX director trades from the last week Welcome to HotCopper’s Director Trades column, where we take a look at all the most interesting director transactions from across the past week and break down the details. This week, we’ll look at Nov. 28 to Dec. 5.Listen to the HotCopper podcast for in-depth discu...
Forget AI: The real tech boom is here For the last two years, artificial intelligence (AI) has dominated every conversation. Politicians, chief executive officers and the media have crowned it the revolution of the decade. But while the world has been fixated on AI, another force has been rising quietly in the background.Listen to th...
HotList Stocks: Ore Resources, US1 CritMins, and other trending Week 49 companies Ore Resources has long been a popular stock on the HotCopper forums as it progresses, and Week 49 was no different for the HotList leader.
NextDC lands ChatGPT owner OpenAI as big-fish customer worth as much as $7 billion NextDC (ASX:NXT) has agreed to build a blockbuster $7 billion data centre in Sydney’s Eastern Creek for ChatGPT owner OpenAI, which will run artificial intelligence models and stand as the largest in the southern hemisphere.Listen to the HotCopper podcast for in-depth discussions ...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.